JPS60186260A - Powdery mushroom extract composition - Google Patents
Powdery mushroom extract compositionInfo
- Publication number
- JPS60186260A JPS60186260A JP59035371A JP3537184A JPS60186260A JP S60186260 A JPS60186260 A JP S60186260A JP 59035371 A JP59035371 A JP 59035371A JP 3537184 A JP3537184 A JP 3537184A JP S60186260 A JPS60186260 A JP S60186260A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- mushroom
- cyclodextrin
- composition
- mushrooms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Fruits And Vegetables (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は健康食品として有用な粉末キノコ類エキス組成
物に関し、更に詳しくは、キノコの子実体及び/又は菌
糸体の抽出物とサイクロデキストリンよシ成る粉末キノ
コ類エキス組成物であって、粉末特性が改良された組成
物に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a powdered mushroom extract composition useful as a health food, and more particularly to a powdered mushroom extract composition comprising an extract of mushroom fruiting bodies and/or mycelium and cyclodextrin. The present invention relates to a composition having improved powder properties.
従来よシキノコは食用又は薬用として、盛んに用いられ
てきたが、近年のキノコ栽培技術の進歩は、各種のキノ
コの子実体又はそれらの菌糸体を大量に提供することに
成功している。Traditionally, mushrooms have been widely used for food or medicine, but recent advances in mushroom cultivation technology have succeeded in providing large quantities of the fruiting bodies of various mushrooms or their mycelia.
従って、食用キノコは単なる食用とするだけでなく、ま
た、薬用キノコは漢方票としての限定された剤型で用い
られるだけでなく、広く健康食品、、各種の形態で市販
されまたは、自家調製し、消費されるに至っている。例
えば、薬用キノコの子実体又は菌糸体は、通常熱水抽出
物をそのまま、又はデキストリン,乳糖若しくはカル?
キシメチルセル?ロース(CMC)等の粉末化剤で粉末
化したものが利用されている。特しサルノコシカ?ケ科
の仲間には制ガン作用があるとして、伝承的に民間楽と
して用いられてきたが、就中、カワラタケはタンク培養
VC得られた菌糸体の熱水抽出物が抗a痢剤として用い
られ注目を集めている。Therefore, edible mushrooms are not only edible, but also medicinal mushrooms are not only used in a limited form as Chinese medicine, but also widely used as health foods, commercially available in various forms, or home-prepared. , has come to be consumed. For example, the fruiting bodies or mycelia of medicinal mushrooms are usually extracted directly from hot water, or extracted with dextrin, lactose, or calcium.
Xymethyl cell? It is used after being powdered with a powdering agent such as loin (CMC). Especially the monkey deer? Members of the family Mosquitoceae are said to have anticancer properties and have traditionally been used as folk music, but in particular, the hot water extract of the mycelium obtained from tank culture of C. versicolor has been used as an antidiarrheal agent. It is attracting attention.
しかし・抽出物をそのまま用“るにして這・1ノコの子
実体又は菌糸体を漢方処方によシ長時間煎じるなどの手
間がかかるか、又、広く市堅に供するとしても抽出物は
一般にl色状であるので抽.出物中の有効成分が変質し
やすいとか、その取扱いが煩雑である等の理由で市販に
供するにあたって、上述の如き粉末化剤を用いたキノコ
抽出物の粉末化物が提供されている。しかし、いずれも
キノコ抽出物に由来する吸湿性等のため、ケーキングを
起こしやすいなど、粉末化物中のキノコ抽出物含量を高
めることができないという欠点があった。However, if the extract is used as it is, it takes time and effort to decoct the fruiting body or mycelium of a single plant using Chinese herbal medicine, and even if it is widely used for Ichiken, the extract is generally not used. Due to the fact that the active ingredients in the extract are easily deteriorated due to its color, and the handling is complicated, powdered mushroom extracts using the above-mentioned powdering agents are not suitable for commercial use. However, due to the hygroscopicity derived from the mushroom extract, both have the disadvantage that they tend to cause caking and cannot increase the mushroom extract content in the powdered product.
皐こで、本発明者は、キノ・抽出物含蚕が高めやれ且つ
、粉末化物の吸湿性特性を改良すべく、多角的に研究し
た結果、粉末化剤としてサイクロデキストリンを用いる
ことによシ上記欠点を解消した粉末キノコ類エキス組盛
物を製造与ることに成功し、本発明を完成した。In order to increase the content of silkworms in kino extract and to improve the hygroscopic properties of powdered products, the present inventor conducted multifaceted research and found that the use of cyclodextrin as a powdering agent was effective. The present invention has been completed by successfully producing a powdered mushroom extract composition that eliminates the above-mentioned drawbacks.
本発明にいう.キノコとは、担子菌類.,(Basld
1omycetes)及び子のう菌fil(Ascom
ycetea)に.属す.る.仲間であって、繁殖器官
である胞子が子実層を有する子実体内に形成されるもの
をいい、?これらの中、?本発明の.目的に供(得る.
もの.奪全て含む。具体的.には、食用及び/又は薬.
用とルて現笑に用いられているキ.ノコを意味する.。In the present invention. Mushrooms are basidiomycetes. , (Basld
1omycetes) and Ascomycetes fil (Ascom
ycetea). Belongs. Ru. A member of the family, spores, which are reproductive organs, are formed within a fruiting body that has a fruiting layer. Among these? of the present invention. To serve (obtain) a purpose.
thing. Including all robberies. concrete. Food and/or medicine.
Ki that is used in real laughter. It means a saw. .
従って、よシ具体的には、シイタケ(Lentlnus
sdodes)、エノキタケ(Flammul1ave
lutlpea)、ヒラタケ(Pleurotusos
treatu++))ナメコ(Pholiotanar
nsko)、マツタケ(Tricholomamats
utaks)又はキク2グ(Aurlcularlam
uriculaJudae)等の食用キノコ及び、マン
ネンタケ(Ganodarmalucldum)、カワ
ラタケ(Corlolusverajeolor)、マ
ツホド(For1mcocos)若しくはテヨレイマイ
タケ(Polyporugumbellatus)又は
これらの近縁稙等を皐げることかできるが、就中、シイ
タケ,マンネンタケ及びカワ2タケ鼓びにこれらの近縁
柚が好適であ.る。Therefore, more specifically, shiitake mushrooms (Lentlnus
sdodes), enokitake (Flammul1ave)
lutlpea), oyster mushroom (Pleurotusos
treatu++)) Nameko (Holiotanar)
nsko), matsutake (Tricholomamat)
utaks) or chrysanthemums (Aurlcularlam)
uricula Judae); edible mushrooms such as Ganodarmalucldum, Corlolus verageolor, For1mcocos, and Polyporugumbellatus; You can strengthen your relationship with Shiitake mushrooms, among others. These closely related citrons are suitable for stone mushrooms and Kawa2take mushrooms. Ru.
特にマンネンタケの近縁柚としては、サルノコシヵケ科
(Polyporaceae)に属し、マゴジャクシ(
G.neo−japonicum)、ツガノマンネンタ
ケ(G.tsugae)等が羊けられ、レイシ(1!芝
)と俗称されるものを全て含む。.
本発明Vc川いられる子笑体とu、IM糸の組絨化と分
化作用によって形成される子実層<m子形成層)の母体
をいい、天産物の採取物又れ純粋培養植菌栽培法による
収穫物として入手できる。また、菌糸体は胞子をも宮む
概念で、上記キノコ鴎をそれ自体公知の栄誉培地で培養
することによル得られる培黛物から、分陥梢製次いで乾
燥処理するそれ自体公知の力法(例えば、特公昭56−
14276号公報番照)で調装できる。In particular, yuzu, which is closely related to Polyporaceae, belongs to the family Polyporaceae and is known as the yuzu citrus (Polyporaceae).
G. neo-japonicum), G. tsugae, etc., and all that are commonly called Reishi (G. tsugae). .. In the present invention, Vc refers to the parent body of the cambium <m cambium) formed by the cambialization and differentiation of IM threads, and is a collection of natural products or a pure culture inoculation. It can be obtained as a harvested product through cultivation methods. In addition, the mycelium is a concept that also harbors spores, and the culture material obtained by culturing the above-mentioned mushroom seaweed in a well-known honor medium is used to form seedlings, which are then dried. law (e.g., Special Publick Act 1986-
14276)).
また本発明にいう、キノコの子.失体及び菌糸体の抽出
物は、前者にあっては必要に応じて数ミリ角から数セン
チ角に切断し、約1<)0.9(固形分)当シ、300
mlから2lの水を60ないし100℃で、6ないし4
8時間浸出した浴液を濃紬するか、減圧乾燥等によシ調
製した液状物又は乾燥物をいう。なお、キノコの種類に
よっては、抽出水にメタノール,エタノール又・はアセ
トン等を混和した溶媒を用いてもよい。Also, mushroom children according to the present invention. In the case of the former, the extract of the exfoliating body and mycelium is cut into pieces of several millimeters to several centimeters square as necessary, and the extract is made into approximately 1<)0.9 (solid content), 300
ml to 2 liters of water at 60 to 100°C, 6 to 4
It refers to a liquid or dried product prepared by concentrating the bath liquid that has been infused for 8 hours or by drying under reduced pressure. Note that depending on the type of mushroom, a solvent prepared by mixing methanol, ethanol, acetone, etc. with extraction water may be used.
一方、本発明に用いられるサイクロデキストリンとして
は、澱粉又はデキストリンにサイクロデキストリン・グ
リコシルトランスフェ1ラーゼ(CGTaaa,E.C
.,2・4.1・19)を作用させて得られるものであ
れば良く、このようにして得られるザイクロデキスト.
リン(以下1’−CD.Jという)のうち、6個のグル
コースが環状にα−1,4結合したα一CD17個のグ
ルコースよシ成るβ一CD若しくは8個のグルコースよ
シ成るr−CDをそれぞれ単独か若しくはそれらの混合
物か、又は未反応のrキストリンを含む#素反応生成物
(通常CD含坩は、約20〜60重針パーセントである
)を脱色粉末化したCD含有物が挙けられる。On the other hand, as the cyclodextrin used in the present invention, cyclodextrin glycosyltransferase (CGTaaa, E.C.
.. , 2, 4.1, 19), and the zychlodext obtained in this way.
Among phosphorus (hereinafter referred to as 1'-CD.J), 6 glucoses are cyclically linked with α-1,4 α-CD, β-CD consisting of 17 glucoses, or r-CD consisting of 8 glucoses. A CD-containing material is obtained by turning CD alone or a mixture thereof, or a # elementary reaction product containing unreacted r-kistrin (usually a CD-containing crucible is about 20 to 60 percent heavy needles) into a decolorized powder. Can be mentioned.
これらのうち、均一な品質の粉末キノコ類エキス組成物
を得る観点からは、β−CDを単独で用いるのが好1し
い。Among these, from the viewpoint of obtaining a powdered mushroom extract composition of uniform quality, it is preferable to use β-CD alone.
次に、本発明で提供される粉末キノコ類エキス組成物は
、上述のキノコの子実体又は菌糸体の抽出物と、CDと
をそれ自体公知の混練法に準じて処理することによDW
造することができる。すなわち、該抽出物の水スラリー
にCDを冷加し、ボールミル,捕漬機等で良く混練した
後、混線物を凍結乾燥,通風乾燥,噴縛乾繰または減圧
乾燥などの方法で乾燥し、必要に応じて粉砕すれば目的
とする初末キノコ唄エキス組成物が得られる。Next, the powdered mushroom extract composition provided by the present invention is obtained by processing the above-mentioned mushroom fruiting body or mycelium extract and CD according to a kneading method known per se.
can be built. That is, after cooling the CD into the water slurry of the extract and thoroughly kneading it with a ball mill, a pickling machine, etc., the mixed material is dried by a method such as freeze drying, ventilation drying, blow drying, or vacuum drying. If necessary, it can be pulverized to obtain the desired Hatsume Mushroom Song extract composition.
上記、混線に際して使用する該抽出物とCDとの比率は
、A!J者の固形分換初−1重瀘部当たJ0.5量
箪一部以上のCDが用いられ、商品価値を考嵐す量
ると、05ないし5,0重一部のCDを用いるのが好適
である。The ratio of the extract and CD used in the above crosstalk is A! A CD with a weight of 0.5 or more is used per 1 part of the solid content of the J person, and when considering the commercial value, a CD of 0.5 to 5.0 parts is used. is preferable.
また、混合に際して、操作の容易性のため加水して固形
分濃度を20ないし60%程kとし、粘性を調整しても
よい。Further, during mixing, for ease of operation, water may be added to adjust the solid content concentration to approximately 20 to 60%, thereby adjusting the viscosity.
混練条件としては、充分混合せしめればよく、特に限定
されるものではないが、辿常≧≦温下30分以上混練す
ればよい。The kneading conditions are not particularly limited as long as sufficient mixing is achieved, but the kneading may be carried out at normal temperatures for 30 minutes or more.
以下に本発明の粉末キノコ類エキス組成物のめ用件を実
験例に基づいて説明する。The requirements of the powdered mushroom extract composition of the present invention will be explained below based on experimental examples.
実験例i.粉末レイシ(マンネンタケ)エキスN1成物
マンネンタケ抽出物(市販レイシエキス(三国(株)製
,固形分40%))を100gづつ10ケの500ml
容ビーカーに1oケ準備し下表に示す粉末化用の添加物
を夫々40g(レイシエキス固形分当シ当M)及びso
g(レイシエキス固形分当92倍量)象加し、各ビーカ
ーに150ゴの水を加えスターラーで室温にて90分間
゛混台した。Experimental example i. Powdered Ganoderma extract N1 ingredient Ganoderma extract (commercially available Ganoderma extract (manufactured by Mikuni Co., Ltd., solid content 40%)) in 500 ml of 10 pieces of 100 g each
Prepare 1 liter beaker and add 40 g each of the additives for powdering shown in the table below (Reishi extract solid content per M) and soybean paste.
150 grams of water was added to each beaker and stirred at room temperature for 90 minutes using a stirrer.
充分混合後凍結乾燥によシ乾燥し粉砕後粉末レイシエキ
ス組成物を得た。After thorough mixing, the mixture was lyophilized and ground to obtain a powdered Ganoderma extract composition.
各々の添加物によシ作成した粉末レイシエキス組成物を
直径9備のシャーレに21づつ採シ室内に1日放置し、
ケーキングの有無を調べ、別に得られた各粉末を用いレ
イシエキス含讐が5%となるように水溶液を作成し、1
0人のパネラーにょシ感応検責を行ない、レイシエキス
そのものの苦みを100点満点として各サンプルの順位
づけをさぜた。結呆を第1表に示す。The powdered reishi extract composition prepared using each additive was placed in 21 Petri dishes each with a diameter of 9 and left in the sampling room for one day.
The presence or absence of caking was examined, and an aqueous solution was prepared using each powder obtained separately so that the Reishi extract content was 5%.
A panelist conducted a sensitivity test and ranked each sample based on the bitterness of the reishi extract itself on a 100-point scale. The results are shown in Table 1.
第1懺よシ明らかなように、添加董がレイシエキス固形
分当シ2倍重量まででは、ケーヤングを起さないレイシ
粉末となったのはβ−サイクロデキストリン区及びサイ
クロrキストリン類区のみであった。又レイシエキスの
有する苦みを和らげる効果を示したのもβ−サイクロr
キストリン区及びザイクロデキストリン類区のみであっ
た。As is clear from the first test, when the amount of added radish was up to twice the weight of the solid content of Ganoderma extract, it was only in the β-cyclodextrin and cyclo-kistrin groups that the reishi powder did not cause Kay Young. there were. β-cyclor also showed the effect of alleviating the bitterness of Reishi extract.
It was found only in the kistrin group and the zychlodextrin group.
実験例2.粉末シイタケエキス組成物
シイタケ抽出物(市販の椎茸エキス(固形分42.71
))を10019づツ500ml容ビーカーK10ケ準
備し第2表に示す粉末化用の添加物を夫夫42.79C
椎茸エキス固形分当シ当瀘)及び85.419(椎茸エ
キス固形分当シ2倍thl)添加し、各ビーカーに15
0a/の水を加えスターラーで室温にて90分間混合し
た。充分混合後凍結乾燥によシ乾燥し、粉砕後粉末シイ
タケエキス組成物を得た。Experimental example 2. Powdered shiitake extract composition Shiitake extract (commercially available shiitake extract (solid content 42.71
)) Prepare 10 500ml beakers each containing 10,019 kg, and add 42.79 ml of the additives shown in Table 2 for powdering.
Add shiitake mushroom extract (solid content) and 85.419 (Shiitake mushroom extract solid content: 2x thl) to each beaker.
0a/ml of water was added and mixed using a stirrer at room temperature for 90 minutes. After thorough mixing, the mixture was lyophilized to obtain a powdered shiitake mushroom extract composition.
各添加物を加え作成した椎茸エキス粉末を直径93の7
ヤーレに21づつ取シ室内に1日放置し、ケーキングの
有無を調べ、別に得られた各添加物による椎茸エキス粉
末を用い、椎茸エキス含量が5俤となるように水溶液を
夫々作成し、10人のパネ2−による感応検査を行ない
、椎茸エキスそのものの風味を100点満点として各サ
ンプルの順イ髪r
位一けをさせた。結果を第2表に示す。Shiitake mushroom extract powder made by adding each additive to 7cm diameter 93mm
21 pieces of Yare were left in a sampling chamber for 1 day, and the presence or absence of caking was examined.Using separately obtained shiitake mushroom extract powder with each additive, an aqueous solution was prepared so that the shiitake mushroom extract content was 5 pieces. A sensitivity test was conducted using a human panel, and the taste of the shiitake mushroom extract itself was ranked on a scale of 100 to 1 for each sample. The results are shown in Table 2.
第2表よシ明らかなように添加物の添加董が椎茸エキス
固形分尚・シ2倍重itまででは、ケーキングを起さな
い粉末シイタケエキス組成物となったのはβ−サイクロ
5P′キストリン区及びサイクロデ侮ストリン類区のみ
であった。又風味についても若干薄まる感じはあるもの
の、ザイクロデキストリン添加区では苦味が全く感じら
れなくなシ、マイルドな風味を呈した。As is clear from Table 2, when the additive is added to the solid content of shiitake extract and the solid content is up to 2 times the weight, the powdered shiitake extract composition that does not cause caking is obtained by β-cyclo5P' kistrin. It was found only in the ward and cyclode-sugar tract. In addition, although the flavor seemed to be slightly diluted, in the zyclodextrin-added group, no bitterness was felt at all, and the flavor was mild.
従って本発明の組成物は目的に応じてビタミン#41そ
の他の栄養素との混入も容易となる。Therefore, the composition of the present invention can be easily mixed with vitamin #41 and other nutrients depending on the purpose.
以上で示される効果は、1ンネンタケ及びシイタケ以外
のキノコ類でも同様に発現した。The above-mentioned effects were similarly expressed in mushrooms other than M. chinensis and shiitake.
ζれらの効果の発現は、キノコ類抽出物に含まれる多糖
@,蛋白質,各種のアミノ酸,脂肪,ビタミン,核酸等
と、また、キノコのm類によクては、各種のアルカロイ
ド類とCDとの何等かの相互作用によるものと考えられ
る。The expression of these effects is due to the polysaccharides, proteins, various amino acids, fats, vitamins, nucleic acids, etc. contained in mushroom extracts, and depending on the type of mushroom, various alkaloids. This is thought to be due to some kind of interaction with the CD.
ただし、環状構造を有しない通常のデキストリンを用い
た中ノコ類粉末化物は、ケーキングを起むさない製品を
得るためには、固形分換算でキノコの子実体又は菌糸体
の抽出物の1重量部癲たシ、5重殖部以上のデキストリ
ンを用いなければならないだけでなく、例えケーキング
を起こさない製品が得られたとしても、抽出物が苦味を
呈するものである場合は、その苦味が除去されないから
である。However, in order to obtain a product that does not cause caking, powdered mushrooms using ordinary dextrin that does not have a cyclic structure must contain 1 part by weight of the mushroom fruiting body or mycelium extract in terms of solid content. Not only is it necessary to use a dextrin with a quintuple or higher dextrin content, but even if a product that does not cause caking is obtained, if the extract is bitter, the bitterness cannot be removed. It is from.
以下に実施例を示し、本発明を更に詳細に説明する。EXAMPLES The present invention will be explained in more detail by way of Examples below.
実施例1
市販レイシエキス(三国(株)製,固形分40チ)1.
0kllにβ−サイクロfキストリンCRsNaotx
−Br99%wt/wt,三楽オーシャン(株)J!l
!)600gを加え、更に水を1.OIl添加し、常温
で90分間撹拌後、凍結乾煉によシ乾燥した。乾燥後粉
砕し、950gの粉末レイシエキス組成物が得られた。Example 1 Commercially available Reishi extract (manufactured by Mikuni Co., Ltd., solid content 40 g)1.
β-cyclof kistrin CRsNaotx in 0kll
-Br99% wt/wt, Sanraku Ocean Co., Ltd. J! l
! ) 600g and then add 1. After adding OIl and stirring at room temperature for 90 minutes, the mixture was dried by freeze drying. After drying, it was crushed to obtain 950 g of a powdered Ganoderma extract composition.
本品中のレイシエキス含董は40%(wt/vt)であ
)、吸湿性がなく、味も苦味がマイルドになっている決
褐色の粉末でhクた。This product contains 40% (wt/vt) Ganoderma extract and is a dark brown powder with no hygroscopicity and mild taste and bitterness.
上記の対照としてβ−CDの代シにD.E.値204!
4度のデキス}IJンを用いた場合には、同量の使用量
ではレイシエキスの吸湿性の為に得られた粉末はすぐに
ケーキングを起し流動性を失なった。As a control for the above, D. E. Value 204!
When using 4 degrees dextrose (IJ), the resulting powder quickly caked and lost fluidity due to the hygroscopic nature of the reishi extract when used in the same amount.
吸湿性のない良好な粉末を得る為eこは、rキストリン
をβ−CDの場合の4倍量の添加が必要であって、本粉
末中のレイシエキス含量は14.3%(w1/,1)と
なシ、商品価値を著しく損うものとなった。In order to obtain a good powder with no hygroscopicity, it is necessary to add r-kistrin in an amount four times that of β-CD, and the reishi extract content in this powder is 14.3% (w1/, 1) This resulted in a significant loss of product value.
実施例2
市販椎茸エキス(固形分42.0%)l.Okgにβ−
サイクロデキストリン(RxNaotx−BT99チw
t/wt,三楽オーシャン(株)製)650#を加え、
更に1.Oll加水し常温にて90分間攪拌後、凍結乾
燥によシ乾燥した。乾燥後粉砕し、lO20Iの粉末シ
イタケエキス組成物を得た。本品中の椎茸エキス含量は
39.2チ(W1/−1)でらシ、椎茸エキスそのもの
の含貨としては93.5%となシ、はほ粉末で椎茸エキ
スそのものとしての取シ扱いが出来る。Example 2 Commercially available shiitake mushroom extract (solid content 42.0%) l. β- to Okg
Cyclodextrin (RxNaotx-BT99chi w
Add t/wt, manufactured by Sanraku Ocean Co., Ltd.) 650#,
Furthermore 1. After adding Oll water and stirring at room temperature for 90 minutes, the mixture was dried by freeze-drying. After drying, it was pulverized to obtain a powdered shiitake extract composition of 1O20I. The content of shiitake mushroom extract in this product is 39.2% (W1/-1), and the content of shiitake mushroom extract itself is 93.5%.It is handled as powdered shiitake mushroom extract itself. I can do it.
本粉末は吸湿性がなく、味も特に苦味がマスクされ、マ
イルドな風味を呈するものでオシ、各柚健康食品又は椎
茸茶の原料として良好なものである。This powder has no hygroscopicity and has a mild flavor with particularly masked bitterness, making it suitable as a raw material for citrus, yuzu health foods, or shiitake mushroom tea.
Claims (1)
ロデキストリンよシ成る粉末キノコ類エキス組成り勿。 2.キノコが食用キノコ及び/又は系用キノコである竹
許請求の!+1囲第1項記載の組成物。 3.食用キノコがシイタケ(Lentlnugedod
es)、エノキタケ(Flammullnavelut
1pe)、ヒラタケ(Pjleuro−tu2o−st
reatus)、ナメコ(Phollotar+ams
ko)、マツタケ(Triaholomamatsut
ake)又はキクラグ(Aurlcularlaaur
iculajudae)である特許請求の+l++j囲
第1項又は第2項のいずれかに記載の組成物。 4.桑川キノコが、マンネンタケ(Ganode.rm
aH+cldum)、カワラタケ(Cor−1o1us
versleolor)、マツホド(Porlaeoc
Os)、若しくは、チョレイマイタケ(Polypor
uiumbellatus)又は、これらの近縁種であ
る特許請求の範囲第1項又は第2項のいずれかに記載の
組成物。 5.キノコ子笑体及び/又は菌糸体の抽出物とサイクロ
デキストリンとの組成比率が、固形物重Ik換算で1対
0.5〜5、0である特許請求の範囲第1項,第2項,
第3項又は第4項のいずれかに記載の組成物。[Claims] 1. A powdered mushroom extract composition comprising an extract of mushroom fruiting bodies and/or mycelia and cyclodextrin. 2. Bamboo permit request where mushrooms are edible mushrooms and/or mushrooms for use in the system! +1 The composition according to item 1. 3. The edible mushroom is Shiitake (Lentlnugedod).
es), enokitake (Flammullnavelut)
1pe), Oyster mushroom (Pjleuro-tu2o-st
reatus), Nameko (Phollotar+ams)
ko), Matsutake (Triaholomamatsut)
ake) or Aurlcularlaaur
iculajudae) according to any of claims 1 or 2. 4. Kuwagawa mushroom is Ganode.rm
aH+cldum), Cor-1o1us
versleolor), Matsuhodo (Porlaeoc)
Os) or Choreimaitake (Polypor
3. The composition according to claim 1 or 2, wherein the composition is P. uiumbellatus) or a closely related species thereof. 5. Claims 1 and 2, wherein the composition ratio of the extract of the mushroom spores and/or mycelium to the cyclodextrin is 1:0.5 to 5.0 in terms of solid weight Ik,
The composition according to any one of paragraphs 3 and 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59035371A JPS60186260A (en) | 1984-02-28 | 1984-02-28 | Powdery mushroom extract composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59035371A JPS60186260A (en) | 1984-02-28 | 1984-02-28 | Powdery mushroom extract composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS60186260A true JPS60186260A (en) | 1985-09-21 |
Family
ID=12440036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59035371A Pending JPS60186260A (en) | 1984-02-28 | 1984-02-28 | Powdery mushroom extract composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60186260A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62259564A (en) * | 1986-05-02 | 1987-11-11 | Yakult Honsha Co Ltd | Production of powder of fomes japonicus extract |
KR100380029B1 (en) * | 2000-11-07 | 2003-04-11 | 박경민 | Process for manufacturing powdered seed of a mushroom |
CN1332019C (en) * | 2004-05-26 | 2007-08-15 | 张鑫 | Grifola umbellate zymophyte powder and grifola umbellate polysaccharide producing method and products therefrom |
CN105029395A (en) * | 2014-04-15 | 2015-11-11 | 四川万安石斛产业开发有限公司 | Food, health-caring product or medicine composition enhancing immunity |
JP2016168035A (en) * | 2015-03-13 | 2016-09-23 | 仙波糖化工業株式会社 | Production method of shiitake extract |
US10813960B2 (en) | 2000-10-04 | 2020-10-27 | Paul Edward Stamets | Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD) |
US11752182B2 (en) | 2014-03-10 | 2023-09-12 | Turtle Bear Holdings, Llc | Integrative fungal solutions for protecting bees |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59196066A (en) * | 1983-04-21 | 1984-11-07 | Naganoken Nouson Kogyo Kenkyusho | Basidiomycetous extract agent and production thereof |
JPS60102167A (en) * | 1983-11-08 | 1985-06-06 | Ichiro Shibauchi | Complex nutrient supplementary food |
-
1984
- 1984-02-28 JP JP59035371A patent/JPS60186260A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59196066A (en) * | 1983-04-21 | 1984-11-07 | Naganoken Nouson Kogyo Kenkyusho | Basidiomycetous extract agent and production thereof |
JPS60102167A (en) * | 1983-11-08 | 1985-06-06 | Ichiro Shibauchi | Complex nutrient supplementary food |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62259564A (en) * | 1986-05-02 | 1987-11-11 | Yakult Honsha Co Ltd | Production of powder of fomes japonicus extract |
JPH0221790B2 (en) * | 1986-05-02 | 1990-05-16 | Yakuruto Honsha Kk | |
US10813960B2 (en) | 2000-10-04 | 2020-10-27 | Paul Edward Stamets | Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD) |
US10821145B2 (en) * | 2000-10-04 | 2020-11-03 | Paul E. STAMETS | Integrative fungal solutions for protecting bees |
KR100380029B1 (en) * | 2000-11-07 | 2003-04-11 | 박경민 | Process for manufacturing powdered seed of a mushroom |
CN1332019C (en) * | 2004-05-26 | 2007-08-15 | 张鑫 | Grifola umbellate zymophyte powder and grifola umbellate polysaccharide producing method and products therefrom |
US11752182B2 (en) | 2014-03-10 | 2023-09-12 | Turtle Bear Holdings, Llc | Integrative fungal solutions for protecting bees |
CN105029395A (en) * | 2014-04-15 | 2015-11-11 | 四川万安石斛产业开发有限公司 | Food, health-caring product or medicine composition enhancing immunity |
JP2016168035A (en) * | 2015-03-13 | 2016-09-23 | 仙波糖化工業株式会社 | Production method of shiitake extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2359338C (en) | Bacillus subtilis takemi and use thereof | |
KR102239305B1 (en) | Method for preparing powder of mycelium using mushroom medium and grain fermentation powder | |
CN104041893B (en) | A kind of production method of the sea-buckthorn liquid that ferments | |
FR2501232A1 (en) | POLYSACCHARIDES COMPRISING ANTI-CARCINOGENIC ACTIVITY AND PROCESS FOR THE PRODUCTION THEREOF | |
CA1088443A (en) | Method of producing polysaccharides | |
JP4807941B2 (en) | β-glucan | |
JPS60186260A (en) | Powdery mushroom extract composition | |
KR20150105700A (en) | a food additive process using mushroom and containing food additive dough | |
Choi et al. | Enhancement of anti-complementary and radical scavenging activities in the submerged culture of Cordyceps sinensis by addition of citrus peel | |
JP2004315512A (en) | Functional composition | |
WO1995018626A1 (en) | A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof | |
JP3443070B2 (en) | Method for deodorizing garlic and health food | |
RU2608497C1 (en) | Mushroom beer and preparation method thereof | |
JP2000159808A (en) | Method for separating and purifying basidiomycota hypha extract | |
JPH04108368A (en) | Mushrooms juice and production thereof | |
CN111718857B (en) | Culture method of sparassis crispa, sparassis crispa dry powder, solvent extract and application thereof | |
JP2008208104A (en) | Antioxidant, and food and drink | |
KR20030072417A (en) | Manufacture method of a functional tea and food, using extract of mushroom mycelium by new extraction technique. | |
KR101856693B1 (en) | Method for preparing fermented mixture comprising Laminaria japonica, Undaria pinnatifida Suringer and hizikia fusiforme and composition for enhancing antioxidant activity and immune activity comprising fermented mixture prepared thereby | |
JP2016034274A (en) | Agp degrading enzyme-producing bacterium | |
KR100261040B1 (en) | The manufacturing process of freeze dried block with fragrant mushroom | |
TW565430B (en) | Incubation method for obtaining solid culture of Zang Zhi, solid culture obtained therefrom | |
JP2004222676A (en) | Method for culturing bacillus natto and method for producing viscous material | |
JP2908357B2 (en) | Method for extracting useful components from mycelium-containing medium | |
JP2001103927A (en) | Method of producing agaricus blazei murill extract having high antitumor activity |